TGA Approval

REMSIMA infliximab 120 mg solution for injection prefilled syringe in auto-injector pen (326188)

ARTG ID

326188

ARTG Name

REMSIMA infliximab 120 mg solution for injection prefilled syringe in auto-injector pen

Sponsor

Celltrion Healthcare Australia Pty Ltd

ARTG Date

November 12, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Celltrion Healthcare Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01619-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-02540-1

Ingredient Name

Infliximab

Empowering clinical research with data-driven insights and AI-powered tools.

REMSIMA infliximab 120 mg solution for injection prefilled syringe in auto-injector pen (326188) - TGA 批准文号 | MedPath